Omeros

New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores
New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores
TheStreet.com
Big Pharma
Medicare Part D
Omeros
Omnibus Bill
Flag link:
5 Small Biotechs Receive Shots in the Arm
5 Small Biotechs Receive Shots in the Arm
TheStreet.com
earnings
Synergy Pharmaceuticals
Omeros
BioDelivery Sciences
Heron Therapeutics
Dynavax
Flag link:
Omeros defends its drug, but still won’t answer basic questions
Omeros defends its drug, but still won’t answer basic questions
Stat
Omeros
OMS721
Flag link:
These 3 Biotech Stocks Have Doubled This Year; Can They Keep Climbing?
These 3 Biotech Stocks Have Doubled This Year; Can They Keep Climbing?
Motley Fool
biotech
Omeros
Cara Therapeutics
Portola Pharmaceuticals
Flag link:
Biotech Movers: OncoMed, Incyte, Omeros
Biotech Movers: OncoMed, Incyte, Omeros
TheStreet.com
biotech
OncoMed
tarextumab
small cell lung cancer
Incyte
Eli Lilly
baricitinib
Omeros
Flag link:
Omeros Kidney Drug Reports Good Results
Omeros Kidney Drug Reports Good Results
Investopedia
Omeros
OMS721
kidney disease
Flag link:
Omeros' Pipeline Is Largely Neglected
Omeros' Pipeline Is Largely Neglected
Seeking Alpha
Omeros
OMS824
OMS721
Qmidria
Flag link:
FDA fast-tracks Omeros' kidney drug as company moves into Phase 3 tests
FDA fast-tracks Omeros' kidney drug as company moves into Phase 3 tests
Bizjournals.com
FDA
fast track
Omeros
OMS721
kidney disease
Flag link:
Omeros notches $13 million in sales of first drug
Omeros notches $13 million in sales of first drug
Bizjournals.com
Omeros
Omidria
post-surgical pain
Flag link:
Omeros CEO: For biotechs, better to be a jack of all trades than a master of one
Omeros CEO: For biotechs, better to be a jack of all trades than a master of one
Bizjournals.com
Omeros
Flag link:
What Lit a Fire Under These 3 Pharma Stocks
What Lit a Fire Under These 3 Pharma Stocks
24/7 Wall St
Aveo Pharmaceuticals
Omeros
Corbus Pharmaceuticals
Flag link:
Omeros Corporation: Another Biotech Bubble In The Making?
Omeros Corporation: Another Biotech Bubble In The Making?
Yahoo/Benzinga
Omeros
OMS721
Soliris
aHUS
Flag link:
Omeros reports 4Q loss
Omeros reports 4Q loss
Yahoo/AP
Omeros
earnings
Flag link:
Omeros suspends OMS824 trial in Huntington's Disease
Omeros suspends OMS824 trial in Huntington's Disease
Seeking Alpha
Omeros
OMS824
Huntington's disease
Flag link:
FDA approves Omeros eye drug
FDA approves Omeros eye drug
Yahoo/Reuters
FDA
Omeros
Omidria
cataracts
Flag link:
2nd Half Of 2014 Biotechnology Catalysts: Part 1
2nd Half Of 2014 Biotechnology Catalysts: Part 1
Seeking Alpha
AcelRx
Anacor
BioDelivery Sciences
Eagle Pharmaceuticals
MannKind
Navidea Biopharmaceuticals
Orexigen
Omeros
EnteroMedics
Progenics
Trimel Pharmaceuticals
Flag link:
Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.
Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.
Motley Fool
Medicines Company
Omeros
OPKO Health
Vivus
OMS721
Qsymia
Fibrocaps
Flag link:
Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros
Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros
Motley Fool
Dendreon
AbbVie
Omeros
Provenge
prostate cancer
ABT-450
hepatitis C
OMS721
Flag link:
3 Under-the-Radar Biotech Stocks You Need to Watch in 2014
3 Under-the-Radar Biotech Stocks You Need to Watch in 2014
Motley Fool
Nektar
Omeros
Spectrum Pharmaceuticals
Flag link:
Omeros Corp reports additional positive phase 1 clinical data for Oms824 for the treatment of cognitive disorders
Omeros Corp reports additional positive phase 1 clinical data for Oms824 for the treatment of cognitive disorders
Reuters
Omeros
OMS824
cognitive disorders
Flag link:

Pages